in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Mylan's $1.6 billion acquisition of Indian generic pharma group Agila expected to get clearance
August 17, 2013 | Natasha Alperowicz
Mylan’s (Canonsbury, PA) $1.6-billion takeover of Agila Specialties (Bangalore, India) is expected to be cleared by the government, Indian media reports citing Anand Sharma, Commerce and Industry Minister. "The present proposals, before the Foreign Investment Promotion Board, or as approved by it, will go through under the existing policy," he said after a meeting on Friday chaired by India’s Prime Minister Manmohan Singh. The takeover, expected to be cleared by the Cabinet Committee of Economic Affairs, will be one of the largest such...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee